Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A temporary capillary cell type helps skin repair after radiation by promoting blood vessel growth.

Dermoscopy is useful for identifying skin lesions in dogs, with specific features distinguishing infundibular keratinising acanthomas from follicular cysts.

Keratoacanthoma changes as it grows, showing different hair follicle characteristics at each stage.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Multiphoton microscopy effectively images rabbit skin structures in detail without staining and shows differences from human skin.

AIMP1 can boost hair growth by increasing stem cell activity.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The model helps understand how wool fiber structure affects its strength and flexibility.

The substance AS101 can help hair grow by slowing down hair cell aging and boosting a hair growth protein.

MultiKano accurately identifies cell types in complex data better than existing methods.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Isoquercitrin helps hair grow by activating certain cell processes.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Hyaluronic acid fillers for temporal lifting can cause hair loss without scarring.

Injecting hyaluronidase into the artery is effective for treating skin death and hair loss caused by hyaluronic acid fillers.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.